...
首页> 外文期刊>Substance abuse: official publication of the Association for Medical Education and Research in Substance Abuse >Trends in Substance Abuse and Infectious Disease Over 20 Years in a Large Methadone Maintenance Treatment (MMT) Clinic in Israel
【24h】

Trends in Substance Abuse and Infectious Disease Over 20 Years in a Large Methadone Maintenance Treatment (MMT) Clinic in Israel

机译:以色列大型美沙酮维持治疗(MMT)诊所20年来物质滥用和传染病的趋势

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The objective was to study substance abuse, infectious disease, and patient outcomes (retention and substance abuse abstinence) over 2 decades in a large methadone maintenance treatment (MMT) facility within a tertiary-referral medical center. Methods: Prevalence of substance abuse was determined monthly between 1993 (35 patients) and 2013 (350 patients) based on observed random urine tests. On entry, patients were tested for hepatitis C and human immunodeficiency virus (HIV) antibodies. One-year retention and substance abuse abstinence were calculated. Results: At admission, mean age and rate of cocaine and benzodiazepines abuse increased over the years, with no change in the prevalence of hepatitis C (50%) and HIV (<10%). Retention rate increased (P = .008) (range: 42.9%-92.4%; overall: 76.2%) and opiate abstinence also increased (P = .006) (range: 49.1%-85.7%; overall: 68.1%), reflecting outcome improvement over the years. Conclusions: Outcome improvement could be attributed to the staffs growing experience and improvements in treatment but also to changes in patient characteristics over the past 2 decades.
机译:背景:目的是在三级转诊医疗中心的大型美沙酮维持治疗(MMT)设施中研究药物滥用,传染病和患者结局(保留和药物滥用禁制)超过2年的情况。方法:根据观察到的随机尿液测试,在1993年(35例患者)至2013年(350例患者)之间每月测定一次药物滥用的发生率。入院时,对患者进行了丙型肝炎和人类免疫缺陷病毒(HIV)抗体测试。计算了一年的保留和戒毒的禁忌。结果:入院时,可卡因和苯二氮卓类药物的平均年龄和滥用率在过去几年中有所增加,丙型肝炎(50%)和艾滋病毒(<10%)的患病率没有变化。保留率增加(P = .008)(范围:42.9%-92.4%;总体:76.2%)和鸦片戒断也增加(P = .006)(范围:49.1%-85.7%;总体:68.1%),反映了这些年来的结果改善。结论:结果的改善可以归因于工作人员不断增长的经验和治疗的改善,还归因于过去20年中患者特征的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号